{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:23:08Z","timestamp":1790464988248,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T00:00:00Z","timestamp":1271203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s11926-010-0100-7","type":"journal-article","created":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T06:45:31Z","timestamp":1271141131000},"page":"192-197","source":"Crossref","is-referenced-by-count":53,"title":["Cutaneous Manifestations of Dermatomyositis and Their Management"],"prefix":"10.1007","volume":"12","author":[{"given":"Jeffrey P.","family":"Callen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"key":"100_CR1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clindermatol.2006.07.001","volume":"24","author":"JP Callen","year":"2006","unstructured":"Callen JP, Wortmann RL: Dermatomyositis. Clin Dermatol 2006, 24:363\u2013373.","journal-title":"Clin Dermatol"},{"key":"100_CR2","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3899\/jrheum.090549","volume":"36","author":"BB Antiochos","year":"2009","unstructured":"\u2022 Antiochos BB, Brown LA, Li Z, et al.: Malignancy is associated with dermatomyositis but not polymyositis in northern New England, USA. J Rheumatol 2009, 36:2704\u20132710. This study demonstrates that the presence of skin disease is an important risk factor for the presence of malignancy.","journal-title":"J Rheumatol"},{"key":"100_CR3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpeds.2005.10.032","volume":"148","author":"LM Pachman","year":"2006","unstructured":"Pachman LM, Abbott K, Sinacore JM, et al.: Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr 2006, 148:247\u2013253.","journal-title":"J Pediatr"},{"key":"100_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Bendewald","year":"2010","unstructured":"\u2022 Bendewald MJ, Wetter DA, Li X, Davis MD: Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol 2010, 146:26\u201330. This study demonstrated that amyopathic dermatomyositis occurs in about 20% of patients with dermatomyositis and that malignancy may occur in these patients as well.","journal-title":"Arch Dermatol"},{"key":"100_CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344\u2013347.","journal-title":"N Engl J Med"},{"key":"100_CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975, 292:403\u2013407.","journal-title":"N Engl J Med"},{"key":"100_CR7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0781.2004.00115.x","volume":"20","author":"L Dourmishev","year":"2004","unstructured":"Dourmishev L, Meffert H, Piazena H: Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects. Photodermatol Photoimmunol Photomed 2004, 20:230\u2013234.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"100_CR8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2133.2008.08711.x","volume":"159","author":"RQ Klein","year":"2008","unstructured":"Klein RQ, Bangert CA, Costner M, et al.: Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. Br J Dermatol 2008, 159:887\u2013894.","journal-title":"Br J Dermatol"},{"key":"100_CR9","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.1994.03520240067043","volume":"272","author":"JS Kasteler","year":"1994","unstructured":"Kasteler JS, Callen JP: Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed. JAMA 1994, 272:1939\u20131941","journal-title":"JAMA"},{"key":"100_CR10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/DAD.0b013e31818520e1","volume":"31","author":"ES Smith","year":"2009","unstructured":"\u2022 Smith ES, Hallman JR, DeLuca AM, et al.: Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol 2009, 31:61\u201367. This report demonstrates that although there are subtle histopathologic differences between lupus erythematosus and dermatomyositis, these changes are not useful in distinguishing lupus from dermatomyositis in clinical practice.","journal-title":"Am J Dermatopathol"},{"key":"100_CR11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1600-0560.1997.tb01458.x","volume":"24","author":"CM Magro","year":"1997","unstructured":"Magro CM, Crowson AN: The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol 1997, 24:543\u2013552.","journal-title":"J Cutan Pathol"},{"key":"100_CR12","unstructured":"\u2022 Magro CM, Segal JP, Neil Crowson A, Chadwick P: The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis. J Cutan Pathol 2009 Nov 4 (Epub ahead of print). This study demonstrates subtle differences between dermatomyositis and lupus erythematosus, but this testing is not likely to be applicable in clinical practice."},{"key":"100_CR13","first-page":"76","volume":"146","author":"RD Sontheimer","year":"2010","unstructured":"Sontheimer RD: Clinically amyopathic dermatomyositis: what can we now tell our patients? Arch Dermatol 2010, 146:76\u201380.","journal-title":"Arch Dermatol"},{"key":"100_CR14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, et al.: Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001, 357:96\u2013100.","journal-title":"Lancet"},{"key":"100_CR15","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/ard.2004.032714","volume":"64","author":"CE Lampropoulos","year":"2005","unstructured":"Lampropoulos CE, D\u2019Cruz DP: Topical tacrolimus treatment in a patient with dermatomyositis. Ann Rheum Dis 2005, 64:1376\u20131377.","journal-title":"Ann Rheum Dis"},{"key":"100_CR16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0190-9622(84)80263-7","volume":"10","author":"TY Woo","year":"1984","unstructured":"Woo TY, Callen JP, Voorhees JJ, et al.: Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol 1984, 10:592\u2013600.","journal-title":"J Am Acad Dermatol"},{"key":"100_CR17","first-page":"855","volume":"141","author":"GC Ang","year":"2005","unstructured":"Ang GC, Werth VP: Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study. Arch Dermatol 2005, 141:855\u2013859.","journal-title":"Arch Dermatol"},{"key":"100_CR18","first-page":"1231","volume":"138","author":"MT Pelle","year":"2002","unstructured":"Pelle MT, Callen JP: Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Arch Dermatol 2002, 138:1231\u20131233.","journal-title":"Arch Dermatol"},{"key":"100_CR19","first-page":"130","volume":"38","author":"ME Zieglschmid-Adams","year":"1998","unstructured":"Zieglschmid-Adams ME, Pandya A, Cohen SB, Sontheimer RD: The value of methotrexate in dermatomyositis. J Am Acad Dermatol 1998, 38:130\u2013132.","journal-title":"J Am Acad Dermatol"},{"key":"100_CR20","first-page":"65","volume":"142","author":"JC Edge","year":"2006","unstructured":"Edge JC, Outland JD, Dempsey JR, Callen JP: Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol 2006, 142:65\u201369.","journal-title":"Arch Dermatol"},{"key":"100_CR21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.2007.073221","volume":"67","author":"VS Sangle","year":"2008","unstructured":"\u2022 Sangle VS, Sangle SR, D\u2019Cruz DP: Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis. Ann Rheum Dis 2008, 67:723. This is one of several case reports to suggest a place for this agent.","journal-title":"Ann Rheum Dis"},{"key":"100_CR22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archderm.142.1.70","volume":"142","author":"D Sereda","year":"2006","unstructured":"Sereda D, Werth VP: Improvement in dermatomyositis rash associated with the use of antiestrogen medication. Arch Dermatol 2006, 142:70\u201372.","journal-title":"Arch Dermatol"},{"issue":"2 Suppl 1","key":"100_CR23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2004.05.044","volume":"52","author":"U Nadiminti","year":"2005","unstructured":"Nadiminti U, Arbiser JL: Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis. J Am Acad Dermatol 2005, 52(2 Suppl 1):17\u201319.","journal-title":"J Am Acad Dermatol"},{"key":"100_CR24","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM, et al.: A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993, 329:1993\u20132000.","journal-title":"N Engl J Med"},{"key":"100_CR25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","volume":"143","author":"L Chung","year":"2007","unstructured":"\u2022 Chung L, Genovese MC, Fiorentino DF: A pilot trial of rituximab in the treatment of patients with dermatomyositis. Arch Dermatol 2007, 143:763\u2013767. This report demonstrated moderate effects on the muscle disease but only limited response of the skin disease.","journal-title":"Arch Dermatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-010-0100-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-010-0100-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-010-0100-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:49:53Z","timestamp":1559436593000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-010-0100-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["100"],"URL":"https:\/\/doi.org\/10.1007\/s11926-010-0100-7","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,14]]}}}